JP5493730B2 - Dentifrice composition - Google Patents
Dentifrice composition Download PDFInfo
- Publication number
- JP5493730B2 JP5493730B2 JP2009255150A JP2009255150A JP5493730B2 JP 5493730 B2 JP5493730 B2 JP 5493730B2 JP 2009255150 A JP2009255150 A JP 2009255150A JP 2009255150 A JP2009255150 A JP 2009255150A JP 5493730 B2 JP5493730 B2 JP 5493730B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- dentifrice composition
- mass
- isopropylmethylphenol
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 69
- 239000000551 dentifrice Substances 0.000 title claims description 63
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 38
- 239000000796 flavoring agent Substances 0.000 claims description 38
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 37
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 37
- 235000019634 flavors Nutrition 0.000 claims description 35
- 239000003205 fragrance Substances 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 25
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 20
- 239000000194 fatty acid Substances 0.000 claims description 20
- 229930195729 fatty acid Natural products 0.000 claims description 20
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 claims description 20
- 150000004665 fatty acids Chemical class 0.000 claims description 19
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 claims description 18
- 229960003237 betaine Drugs 0.000 claims description 18
- NMRPBPVERJPACX-QMMMGPOBSA-N 3-Octanol Natural products CCCCC[C@@H](O)CC NMRPBPVERJPACX-QMMMGPOBSA-N 0.000 claims description 10
- STZUZYMKSMSTOU-UHFFFAOYSA-N 3-Octyl acetate Chemical compound CCCCCC(CC)OC(C)=O STZUZYMKSMSTOU-UHFFFAOYSA-N 0.000 claims description 10
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 10
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 10
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 10
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 claims description 2
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims 1
- 235000019640 taste Nutrition 0.000 description 31
- -1 acyl sarcosine salt Chemical class 0.000 description 26
- 238000005187 foaming Methods 0.000 description 22
- 230000000844 anti-bacterial effect Effects 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 14
- 230000007794 irritation Effects 0.000 description 14
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 12
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 210000002200 mouth mucosa Anatomy 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 210000000214 mouth Anatomy 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 8
- 238000013329 compounding Methods 0.000 description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 239000003240 coconut oil Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000000873 masking effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229940048084 pyrophosphate Drugs 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000001680 brushing effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 208000003265 stomatitis Diseases 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 208000028169 periodontal disease Diseases 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- 239000000606 toothpaste Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229920001684 low density polyethylene Polymers 0.000 description 4
- 239000004702 low-density polyethylene Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000025157 Oral disease Diseases 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 3
- 229920000092 linear low density polyethylene Polymers 0.000 description 3
- 239000004707 linear low-density polyethylene Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 208000030194 mouth disease Diseases 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- JHWFWLUAUPZUCP-UHFFFAOYSA-N 3-Ethyl-2-hydroxycyclopent-2-en-1-one Chemical compound CCC1=C(O)C(=O)CC1 JHWFWLUAUPZUCP-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- 239000000120 Artificial Saliva Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 241000605986 Fusobacterium nucleatum Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000605862 Porphyromonas gingivalis Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- GNLCVCWRHBBBQC-UHFFFAOYSA-N [Na].NCCNCCO Chemical compound [Na].NCCNCCO GNLCVCWRHBBBQC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- HCRBXQFHJMCTLF-ZCFIWIBFSA-N ethyl (2r)-2-methylbutanoate Chemical compound CCOC(=O)[C@H](C)CC HCRBXQFHJMCTLF-ZCFIWIBFSA-N 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- XJHRZBIBSSVCEL-ARJAWSKDSA-N (Z)-non-6-en-1-ol Chemical compound CC\C=C/CCCCCO XJHRZBIBSSVCEL-ARJAWSKDSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 description 1
- MJTPMXWJHPOWGH-UHFFFAOYSA-N 2-Phenoxyethyl isobutyrate Chemical compound CC(C)C(=O)OCCOC1=CC=CC=C1 MJTPMXWJHPOWGH-UHFFFAOYSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- CNJLMVZFWLNOEP-UHFFFAOYSA-N 4,7,7-trimethylbicyclo[4.1.0]heptan-5-one Chemical compound O=C1C(C)CCC2C(C)(C)C12 CNJLMVZFWLNOEP-UHFFFAOYSA-N 0.000 description 1
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 241000186045 Actinomyces naeslundii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 101100055224 Anemone leveillei AL10 gene Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 1
- BLILOGGUTRWFNI-UHFFFAOYSA-N Monomenthyl succinate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(O)=O BLILOGGUTRWFNI-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- KCFRUUYAXCDZNZ-UHFFFAOYSA-N N-dodecanoyltaurine Chemical class CCCCCCCCCCCC(=O)NCCS(O)(=O)=O KCFRUUYAXCDZNZ-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 229930184148 Spiranthol Natural products 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XJHRZBIBSSVCEL-UHFFFAOYSA-N Z-Non-6-en-1-ol Natural products CCC=CCCCCCO XJHRZBIBSSVCEL-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229940095076 benzaldehyde Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001722 capsicum frutescens oleoresin Substances 0.000 description 1
- 229940050948 capsicum oleoresin Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 125000000422 delta-lactone group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000001813 ethyl (2R)-2-methylbutanoate Substances 0.000 description 1
- 229940090910 ethyl 2-methylbutyrate Drugs 0.000 description 1
- YSNWHRKJEKWJNY-UHFFFAOYSA-N ethyl 3-(methylthio)propionate Chemical compound CCOC(=O)CCSC YSNWHRKJEKWJNY-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940005667 ethyl salicylate Drugs 0.000 description 1
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 1
- 229920005648 ethylene methacrylic acid copolymer Polymers 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 125000000457 gamma-lactone group Chemical group 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940046257 glyceryl phosphate Drugs 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- JHEPBQHNVNUAFL-UHFFFAOYSA-N hex-1-en-1-ol Chemical compound CCCCC=CO JHEPBQHNVNUAFL-UHFFFAOYSA-N 0.000 description 1
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- KWKAKUADMBZCLK-UHFFFAOYSA-N methyl heptene Natural products CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- FVRNDBHWWSPNOM-UHFFFAOYSA-L strontium fluoride Chemical compound [F-].[F-].[Sr+2] FVRNDBHWWSPNOM-UHFFFAOYSA-L 0.000 description 1
- 229910001637 strontium fluoride Inorganic materials 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 229940078465 vanillyl butyl ether Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、イソプロピルメチルフェノール由来の口腔内バイオフィルムへの殺菌作用が高く発揮され、かつ口腔粘膜刺激への刺激が少なく、嫌味が抑制され、使用感に優れると共に、歯磨ブラッシング時の泡立ちも良好である歯磨組成物に関する。 The present invention exhibits high bactericidal action on oral biofilms derived from isopropylmethylphenol, has low irritation to oral mucosal irritation, suppresses taste nuisance, has an excellent feeling of use, and also has good foaming during dentifrice brushing It is related with the dentifrice composition which is.
う蝕、歯周病の2大口腔疾患の原因は、口腔内に形成されるバイオフィルムに起因する感染症であることが知られている。バイオフィルムとは、細菌が物質表面に付着し形成される微生物の共同体のことであり、細菌以外に菌体外多糖などの有機物に覆われることで外部環境に対して保護されているという特徴を有している。口腔内バイオフィルムは形成する部位、即ち疾患原因によって構成する病原性細菌種が異なっており、例えば、う蝕ではストレプトコッカス ミュータンス(S.mutans)等の連鎖球菌、歯周病ではポルフィロモナス ジンジバリス(P.gingivalis)等の偏性嫌気性グラム陰性桿菌を主とした細菌、また口臭の原因としてはフゾバクテリウム ヌクレアタム(F.nucleatum)等の口腔内細菌が関与していることが判っている。従って、口腔内疾患の予防、改善に有効な手段として、口腔内バイオフィルムを形成させないことや、バイオフィルム中の病原性細菌数を低レベルに保つこと、また、口腔内全体として病原性細菌数をコントロールすることが有用と言われている。 It is known that the cause of two major oral diseases, caries and periodontal disease, is an infection caused by a biofilm formed in the oral cavity. A biofilm is a community of microorganisms formed by attaching bacteria to the surface of a substance, and is characterized by being protected against the external environment by being covered with organic substances such as extracellular polysaccharides in addition to bacteria. Have. Oral biofilms have different pathogenic bacterial species depending on the site where they form, for example, streptococci such as S. mutans for caries, and Porphyromonas gingivalis for periodontal disease. It has been found that bacteria mainly composed of obligate anaerobic gram-negative bacilli such as (P. gingivalis) and oral bacteria such as Fusobacterium nucleatum are involved as the cause of bad breath. Therefore, as an effective means for prevention and improvement of oral diseases, do not form oral biofilms, keep the number of pathogenic bacteria in the biofilm at a low level, and count the number of pathogenic bacteria as a whole in the oral cavity. It is said that it is useful to control.
口腔内における病原性細菌は、形成されたバイオフィルム内や唾液中にも浮遊細菌として常在しており、これらの病原性細菌数を低下させるには、トリクロサンなどの難水溶性殺菌剤や塩化セチルピリジニウムなどのカチオン性殺菌剤、その他のアニオン性殺菌剤を用いることが有効とされている。特にバイオフィルム内に存在する細菌に対しては難水溶性殺菌剤であるイソプロピルメチルフェノールが好適に使用されている(特許文献1〜4)。 Pathogenic bacteria in the oral cavity are resident as floating bacteria in the formed biofilm and in saliva. To reduce the number of pathogenic bacteria, water-insoluble fungicides such as triclosan and chloride It is effective to use a cationic fungicide such as cetylpyridinium and other anionic fungicides. In particular, isopropylmethylphenol, which is a poorly water-soluble fungicide, is suitably used for bacteria present in biofilms (Patent Documents 1 to 4).
バイオフィルム内部の病原性細菌に適するとされるイソプロピルメチルフェノールは、バイオフィルム内への浸透性が他の殺菌成分より優れることが知られている。しかし、イソプロピルメチルフェノールを含有する組成物は、特有な嫌味を有するために使用感を著しく損なうという欠点が生じ、この点の改善が求められていた。 Isopropyl methylphenol, which is considered to be suitable for pathogenic bacteria inside the biofilm, is known to have better penetrability into the biofilm than other bactericidal components. However, the composition containing isopropylmethylphenol has a disadvantage that the feeling of use is remarkably impaired because it has a peculiar taste, and improvement of this point has been demanded.
この課題に対し、例えば特定のアシルサルコシン塩をフェノキシエタノールに対し特定の配合割合で組み合わせて配合することで抗菌成分の異味を低減させる技術(特許文献5)、l−メントール及び塩化ナトリウムをイソプロピルメチルフェノールに対して特定の質量比で配合することにより異臭・異味を低減する技術(特許文献6)が提案されている。しかし、アシルサルコシン塩を多く配合した場合にはアシルサルコシン塩由来と考えられる口腔粘膜刺激が生じたり、塩化ナトリウムを配合した場合には塩味により香味のタイプが限定される場合があるなどの新たな課題が生じ、満足な使用感とは言い難かった。 In response to this problem, for example, a technique for reducing the off-flavor of antibacterial components by combining a specific acyl sarcosine salt in combination with a specific mixing ratio with respect to phenoxyethanol (Patent Document 5), l-menthol and sodium chloride with isopropylmethylphenol On the other hand, a technique (Patent Document 6) for reducing off-flavors and off-flavors by blending at a specific mass ratio is proposed. However, when a large amount of acyl sarcosine salt is added, oral mucosal irritation considered to be derived from the acyl sarcosine salt occurs, and when sodium chloride is added, the flavor type may be limited depending on the salty taste. There was a problem and it was difficult to say that it was satisfactory.
また、サッカリンなどの甘味剤により嫌味をマスキングして低減する方法もあるが、この場合は、甘味剤の味が強調され過ぎたりして必ずしも嫌味を抑えることができるとは言えなかった。よって、イソプロピルメチルフェノール由来の嫌味を低減する新たな技術が求められていた。 In addition, there is a method of reducing the taste by masking with a sweetener such as saccharin. However, in this case, the taste of the sweetener is emphasized too much and it cannot always be said that the taste can be suppressed. Therefore, a new technique for reducing the tasting taste derived from isopropylmethylphenol has been demanded.
また、バイオフィルム内の細菌はフィルム(細胞外マトリックス)で覆われているため、抗菌物質に対して高い抵抗性を示し、他の抗菌成分に比べバイオフィルムに対する殺菌効果に優れるイソプロピルメチルフェノールにおいても、より一層その殺菌効果を高める技術が求められていた。 In addition, since bacteria in biofilms are covered with a film (extracellular matrix), isopropylmethylphenol is highly resistant to antibacterial substances and has an excellent bactericidal effect on biofilms compared to other antibacterial components. Therefore, there has been a demand for a technique for enhancing the sterilizing effect.
ところで、歯周病に罹患すると、歯ぐきに強い炎症反応が起こっていることが多く、歯ぐきが物理的及び化学的刺激に敏感になっている場合があり、歯磨き時に痛みや出血といった自覚症状を感じることも多く、この場合、炎症反応を進行させずに歯周病の予防効果を上げることが望ましい。
一方、バイオフィルム内の細菌を殺菌するには覆われているフィルムを破壊又は浸透することで内部まで薬用成分を到達させる必要があり、効果を高めるには必然的に生体に対する作用性が強い物質を用いる必要があるが、これらを配合した場合には口腔粘膜に対しても刺激感を生ずる場合が多く、よって、刺激がないか、あるいは極めて少ない歯磨組成物が求められていた。
By the way, when suffering from periodontal disease, a strong inflammatory reaction often occurs in the gums, and the gums may be sensitive to physical and chemical stimuli, and you feel subjective symptoms such as pain and bleeding when brushing your teeth. In this case, it is desirable to increase the preventive effect of periodontal disease without causing an inflammatory reaction.
On the other hand, in order to sterilize the bacteria in the biofilm, it is necessary to make the medicinal component reach the inside by destroying or permeating the covered film. However, when these are blended, the oral mucosa often gives a sense of irritation, and therefore there has been a demand for a dentifrice composition that is not irritated or very little.
また、歯磨組成物には洗浄実感も求められており、満足な洗浄実感を得るテクスチャーの1つに歯磨き時の泡立ちのよさがある。しかしながら、歯磨き時の泡立ちを良好にするためにアニオン性界面活性剤の配合量を増量すると、口腔内での刺激性が強くなる懸念があり、この点も改善の余地があった。 In addition, the toothpaste composition is also required to have a feeling of cleaning, and one of the textures that provides a satisfactory feeling of cleaning is foaming when brushing. However, when the amount of the anionic surfactant is increased in order to improve foaming during tooth brushing, there is a concern that irritation in the oral cavity becomes stronger, and there is also room for improvement in this respect.
なお一方で、縮合リン酸塩は、金属イオンに対するキレート作用を有することから、口腔用組成物において、歯石を抑制する有効成分や歯の美白効果を得る成分などとして用いられている(特許文献7〜10)。しかしながら、縮合リン酸塩は、その作用メカニズムから、口腔粘膜に対しても影響を与え、歯磨組成物に配合する界面活性剤の種類によって、少なからず口腔粘膜に対する刺激が生じるといった課題があった。この場合、アニオン性界面活性剤の配合量を少なくすると刺激が弱まる傾向はあるが、歯磨時の泡立ちが低下するといった別の課題が生じていた。 On the other hand, since condensed phosphate has a chelating action on metal ions, it is used as an effective ingredient for suppressing tartar, a component for obtaining a whitening effect on teeth, etc. in oral compositions (Patent Document 7). -10). However, the condensed phosphate has an effect on the oral mucosa due to its action mechanism, and there is a problem that irritation to the oral mucosa occurs depending on the type of surfactant to be blended in the dentifrice composition. In this case, if the amount of the anionic surfactant is decreased, the irritation tends to be weakened, but another problem has arisen in that foaming during dentifrice is reduced.
上記したように、イソプロピルメチルフェノールを含有する歯磨組成物においては、イソプロピルメチルフェノール由来の口腔内バイオフィルムへの殺菌作用がより高く発揮され、かつ口腔粘膜刺激への刺激が少なく、嫌味が抑制され使用感に優れると共に、歯磨ブラッシング時の泡立ちも良好であることが求められているが、従来の技術では種々の課題があり、これら全てを満たすことは困難であった。 As described above, in the dentifrice composition containing isopropylmethylphenol, the bactericidal action on the intraoral biofilm derived from isopropylmethylphenol is more highly demonstrated, and there is less irritation to oral mucosal irritation and the taste is suppressed. While it is required to have excellent usability and good foaming during toothbrushing, the conventional techniques have various problems and it has been difficult to satisfy all of them.
本発明は、上記課題を解決するためになされたもので、イソプロピルメチルフェノール由来の口腔バイオフィルムに対する殺菌効果がより高く発揮されると共に、特有な嫌味が低減され、口腔粘膜に対する刺激も少なく、使用感に優れ、しかも、歯磨時の泡立ちも良好な歯磨組成物を提供することを目的とする。 The present invention was made in order to solve the above-mentioned problems, has a higher bactericidal effect on oral biofilms derived from isopropylmethylphenol, has a reduced peculiar taste, has less irritation to the oral mucosa, and is used An object of the present invention is to provide a dentifrice composition that is excellent in feeling and also has good foaming during dentifrice.
本発明者らは、上記目的を達成するため鋭意検討を進めた結果、(A)イソプロピルメチルフェノールと、(B)3−オクタノール、3−オクチルアセテート、3−オクタノンから選ばれる1種又は2種以上の香料成分と、(C)脂肪酸の炭素数が12〜14の脂肪酸アミドプロピルベタイン及び/又は2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタインと、(D)ピロリン酸塩及び/又はトリポリリン酸塩と、(E)ラウリル硫酸塩とを併用し、(D)成分を特定量で配合することにより、口腔バイオフィルムに対する殺菌効果が高まる上、イソプロピルメチルフェノールに特有な嫌味が低減されて嫌味がほとんどなく、口腔粘膜に対する刺激も少なく、良好な使用感を有し、かつ歯磨時の泡立ちも良好な歯磨組成物が得られることを見出し、本発明を完成するに至った。 As a result of intensive studies to achieve the above object, the present inventors have found that (A) isopropylmethylphenol and (B) 3-octanol, 3-octyl acetate, or 1-octane selected from 3-octanone. The above perfume ingredients, (C) fatty acid amidopropyl betaine and / or 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine having 12 to 14 carbon atoms of fatty acid, and (D) pyrophosphate And / or tripolyphosphate and (E) lauryl sulfate are used in combination, and by blending the component (D) in a specific amount, the bactericidal effect on the oral biofilm is enhanced, and the taste taste unique to isopropylmethylphenol Reduced taste, almost no taste, little irritation to the oral mucosa, good usability, and good foaming during dentifrice Found that a dentifrice composition is obtained such, the present invention has been completed.
即ち、本発明によれば、(A)イソプロピルメチルフェノールを含有する歯磨組成物に、(B)成分の特定香料を配合し、かつ(C)〜(E)成分を併用することによって、従来の種々の課題が解決されて、イソプロピルメチルフェノール由来の殺菌効果が高まると共に、特有な嫌味が低減され、口腔粘膜に対する刺激も少なく、使用感に優れ、しかも、歯磨時の泡立ちも良好となり、これら特性を兼ね備えた歯周病等の口腔疾患の予防又は改善に有効な歯磨組成物を得ることができる。 That is, according to the present invention, by blending the specific fragrance of the component (B) with the dentifrice composition containing (A) isopropylmethylphenol and using the components (C) to (E) in combination, Various problems are solved, sterilization effect derived from isopropylmethylphenol is enhanced, peculiar taste is reduced, there is little irritation to the oral mucosa, it is excellent in use feeling, and foaming at the time of dentifrice is also good. Thus, it is possible to obtain a dentifrice composition effective for preventing or ameliorating oral diseases such as periodontal disease.
なお、上記(B)成分の香料成分は、いずれも特徴的な香気を有しており、チーズなどの調合フレーバーに微量用いられることはあるが、それ自体不快な香気であるため、歯磨組成物の香料としての使用は限定的であった。本発明者らは、このような上記(B)成分の特定香料をイソプロピルメチルフェノールと併用して歯磨組成物に配合すると、意外にもイソプロピルメチルフェノール由来の嫌味を十分に抑制できることを見出した。 In addition, since the fragrance | flavor component of said (B) component has characteristic fragrance | flavor and is used for trace amounts of some compound flavors, such as cheese, since it is unpleasant fragrance itself, the dentifrice composition The use as a fragrance was limited. The present inventors have unexpectedly found that when the specific flavor of the above component (B) is used in combination with isopropylmethylphenol in a dentifrice composition, the tasting taste derived from isopropylmethylphenol can be sufficiently suppressed.
更に、本発明では、(D)成分/(A)成分が質量比で10〜50であること、また、(C)成分/(E)成分が質量比で0.4〜2であることが好ましく、このような配合比率とすることで、バイオフィルムに対する殺菌効果をより高めることができる。 Furthermore, in this invention, (D) component / (A) component is 10-50 by mass ratio, and (C) component / (E) component is 0.4-2 by mass ratio. Preferably, the sterilization effect with respect to a biofilm can be heightened more by setting it as such a mixture ratio.
また、本発明では、上記(A)〜(E)成分を配合した歯磨組成物に更に(F)アニスアルデヒドを配合することで、特有な嫌味をより低減でき、使用感を更に改善できる。 Further, in the present invention, by adding (F) anisaldehyde to the dentifrice composition containing the above components (A) to (E), the special taste can be further reduced and the feeling in use can be further improved.
従って、本発明は下記の歯磨組成物を提供する。
請求項1:
(A)イソプロピルメチルフェノール、
(B)3−オクタノール、3−オクチルアセテート、3−オクタノンから選ばれる1種又は2種以上の香料成分、
(C)脂肪酸の炭素数が12〜14の脂肪酸アミドプロピルベタイン及び/又は2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、
(D)ピロリン酸塩及び/又はトリポリリン酸塩、
(E)ラウリル硫酸塩
を含有してなり、(D)成分の配合量が0.1〜2.0質量%であることを特徴とする歯磨組成物。
請求項2:
(D)成分/(A)成分の配合比率が、質量比で2〜100である請求項1記載の歯磨組成物。
請求項3:
(C)成分/(E)成分の配合比率が、質量比で0.1〜5である請求項1又は2記載の歯磨組成物。
請求項4:
(A)成分を0.01〜0.2質量%、(B)成分を0.0001〜0.1質量%、(C)成分を0.1〜2.0質量%、(E)成分を0.2〜2.5質量%含有する請求項1乃至3のいずれか1項記載の歯磨組成物。
請求項5:
更に、(F)アニスアルデヒドを含有する請求項1乃至4のいずれか1項記載の歯磨組成物。
請求項6:
(F)成分を0.0001〜0.1質量%含有する請求項5記載の歯磨組成物。
Accordingly, the present invention provides the following dentifrice composition.
Claim 1:
(A) isopropylmethylphenol,
(B) 1 type, or 2 or more types of fragrance | flavor components chosen from 3-octanol, 3-octyl acetate, and 3-octanone,
(C) Fatty acid amide propyl betaine and / or 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine whose fatty acid has 12 to 14 carbon atoms,
(D) pyrophosphate and / or tripolyphosphate,
(E) A dentifrice composition comprising lauryl sulfate, wherein the blending amount of component (D) is 0.1 to 2.0% by mass.
Claim 2:
The dentifrice composition according to claim 1, wherein the blending ratio of component (D) / component (A) is 2 to 100 in terms of mass ratio.
Claim 3:
The dentifrice composition according to claim 1 or 2, wherein the mixing ratio of component (C) / component (E) is 0.1 to 5 in terms of mass ratio.
Claim 4:
(A) 0.01-0.2 mass% of component, (B) component 0.0001-0.1 mass%, (C) component 0.1-2.0 mass%, (E) component The dentifrice composition of any one of Claims 1 thru | or 3 containing 0.2-2.5 mass%.
Claim 5:
The dentifrice composition according to any one of claims 1 to 4, further comprising (F) anisaldehyde.
Claim 6:
The dentifrice composition of Claim 5 which contains 0.0001-0.1 mass% of (F) component.
本発明の歯磨組成物は、イソプロピルメチルフェノールを含有する組成物が有する特有な嫌味を低減すると共に、バイオフィルムに対して高い殺菌効果が得られると共に、口腔粘膜に対する刺激が少なく歯磨時の泡立ちも良好な歯磨組成物である。 The dentifrice composition of the present invention reduces the peculiar taste that the composition containing isopropylmethylphenol has, has a high bactericidal effect on the biofilm, has little irritation to the oral mucosa, and has foaming during dentifrice. Good dentifrice composition.
以下、本発明につき更に詳細に説明する。本発明の歯磨組成物は、練歯磨、液状歯磨、潤製歯磨等の歯磨剤、特に練歯磨として好適に調製され、(A)イソプロピルメチルフェノール、(B)3−オクタノール、3−オクチルアセテート、3−オクタノンから選ばれる1種又は2種以上の香料成分、(C)脂肪酸の炭素数が12〜14の脂肪酸アミドプロピルベタイン及び/又は2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、(D)ピロリン酸塩及び/又はトリポリリン酸塩、及び(E)ラウリル硫酸塩を含有する。 Hereinafter, the present invention will be described in more detail. The dentifrice composition of the present invention is suitably prepared as a dentifrice such as a toothpaste, a liquid dentifrice, and a toothpaste, especially a toothpaste, and comprises (A) isopropylmethylphenol, (B) 3-octanol, 3-octyl acetate, 1 or 2 or more types of perfume ingredients selected from 3-octanone, (C) fatty acid amidopropyl betaine and / or 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazole having 12 to 14 carbon atoms Nitrobetaine, (D) pyrophosphate and / or tripolyphosphate, and (E) lauryl sulfate.
本発明で用いる(A)イソプロピルメチルフェノールは、4−イソプロピル−3−メチルフェノールであり、例えば、大阪化成(株)製のイソプロピルメチルフェノールなどの市販品を用いることができる。 (A) Isopropylmethylphenol used in the present invention is 4-isopropyl-3-methylphenol, and for example, commercially available products such as isopropylmethylphenol manufactured by Osaka Kasei Co., Ltd. can be used.
(A)イソプロピルメチルフェノールの配合量は、組成物全体の0.01〜0.2%(質量%、以下同様)、特に0.02〜0.1%が好適であり、0.01%未満では十分な殺菌効果が発揮されないことがあり、0.2%を超えると嫌味が生じて味が悪くなる場合がある。 (A) The blending amount of isopropylmethylphenol is preferably 0.01 to 0.2% (mass%, the same applies hereinafter), particularly 0.02 to 0.1% of the whole composition, and less than 0.01%. In some cases, the sufficient bactericidal effect may not be exhibited, and if it exceeds 0.2%, an unpleasant taste may occur and the taste may deteriorate.
(B)成分は、イソプロピルメチルフェノール由来の嫌味をマスキングし、良好な香味を発現させるのに有効な香料成分であり、3−オクタノール、3−オクチルアセテート、3−オクタノン、フェンコンのうち、3−オクタノール、3−オクチルアセテート、3−オクタノンから選ばれる1種又は2種以上の香料成分である。
上記香料成分の2種以上を組み合わせる場合は、3−オクタノールと3−オクチルアセテート及び/又はフェンコンとの組み合わせが好適である。
なお、オクタノールであっても、歯磨組成物の香料として一般的な1−オクタノールはイソプロピルメチルフェノール由来の嫌味をマスキングする効果がなく、本発明にかかわる香料成分として相応しくない。
The component (B) is a fragrance component effective for masking the unpleasant taste derived from isopropylmethylphenol and expressing a good flavor. Among 3-octanol, 3-octyl acetate, 3-octanone, and Fencon , 3- It is one or more perfume ingredients selected from octanol, 3-octyl acetate, and 3-octanone .
When combining 2 or more types of the said fragrance | flavor components, the combination of 3-octanol, 3-octyl acetate, and / or Fencon is suitable.
In addition, even if it is octanol, 1-octanol common as a fragrance | flavor of a dentifrice composition does not have an effect which masks the taste which originates in isopropylmethylphenol, and is not suitable as a fragrance | flavor component concerning this invention.
上記(B)成分は市販品を用いることができ、例えば3−オクタノールは塩野香料(株)の製品、3−オクチルアセテート、3−オクタノンはそれぞれ(株)井上香料製造所の製品などを用いることができる。フェンコンは香栄興業(株)の製品などを用いることができる。 The component (B) may be a commercial product, for example, 3-octanol product Shiono perfume Ltd., 3-octyl acetate, 3-octanone be used as each Ltd. Inoue perfume Mill Products Can do. Fencon can use products from Koei Kogyo Co., Ltd.
(B)成分の総配合量は特に限定されないが、組成物全量に対して、0.0001〜0.1%、特に0.0005〜0.05%、とりわけ0.001〜0.02%が望ましい。配合量が0.0001%未満では、イソプロピルメチルフェノール由来の嫌味をマスキングできず、使用感が悪くなる場合があり、0.1%を超えると、香料成分自体の香味が強すぎて嫌味を生じる場合がある。 (B) Although the total compounding quantity of a component is not specifically limited, 0.0001-0.1% with respect to the composition whole quantity, Especially 0.0005-0.05%, Especially 0.001-0.02% desirable. If the blending amount is less than 0.0001%, it may not be possible to mask the tasting taste derived from isopropylmethylphenol, and the feeling of use may be worsened. If it exceeds 0.1%, the flavoring of the fragrance ingredient itself is too strong, resulting in tasting. There is a case.
(C)成分は、脂肪酸の炭素数が12〜14の脂肪酸アミドプロピルベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタインから選ばれるベタイン型界面活性剤である。
脂肪酸アミドプロピルベタインとしては、脂肪酸の炭素数が12〜14であるものが使用され、ラウリン酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルベタインなどが挙げられ、特にヤシ油脂肪酸アミドプロピルベタインが泡立ちの点で好ましい。また、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタインとしては、N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウム、N-ラウロイル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミンナトリウムなどが挙げられ、特にN−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウムが泡立ちの点で好ましい。
The component (C) is a betaine-type surfactant selected from fatty acid amidopropyl betaine having a fatty acid having 12 to 14 carbon atoms and 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine.
As fatty acid amidopropyl betaine, fatty acid having 12 to 14 carbon atoms is used, and examples thereof include lauric acid amidopropyl betaine and coconut oil fatty acid amidopropyl betaine. Is preferable. Moreover, as 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine sodium, N-lauroyl-N-carboxymethyl- Examples thereof include sodium N-hydroxyethylethylenediamine, and particularly, N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine sodium is preferable in terms of foaming.
ラウリン酸アミドプロピルベタインとしては、例えば、アンヒトール20AB(30%水溶液、花王(株))、ソフタゾリン LPB(30%水溶液、川研ファインケミカル(株))等が用いられる。また、ヤシ油脂肪酸アミドプロピルベタインとしては、アンヒトール55AB(30%水溶液、花王(株))、TEGO BETAIN CK(30%水溶液、Goldschmidt社)、NIKKOL AM−3130N(30%水溶液、日光ケミカルズ(株))などが用いられる。 As lauric acid amidopropyl betaine, for example, Amphithol 20AB (30% aqueous solution, Kao Corporation), Softazoline LPB (30% aqueous solution, Kawaken Fine Chemical Co., Ltd.) and the like are used. Further, as palm oil fatty acid amidopropyl betaine, Amphithol 55AB (30% aqueous solution, Kao Corporation), TEGO BETAIN CK (30% aqueous solution, Goldschmidt), NIKKOL AM-3130N (30% aqueous solution, Nikko Chemicals Corporation) ) Etc. are used.
N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウムとしては、例えば、エナジコールC−40H(40%水溶液(固形分)、ライオン(株))、アンヒトール20Y−B(花王(株))、ソフタゾリンCH(30%水溶液、川研ファインケミカル(株))、ソフタゾリンCL−R(30%水溶液、川研ファインケミカル(株))等が、また、N−ラウロイル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウムとしては、例えばソフタゾリンLHL(27%水溶液、川研ファインケミカル(株))等が用いられるが、いずれの場合も上記に限ったものではない。 Examples of N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine sodium include enadicol C-40H (40% aqueous solution (solid content), Lion Co., Ltd.), Amphital 20Y-B (Kao Co., Ltd.) )), Softazolin CH (30% aqueous solution, Kawaken Fine Chemical Co., Ltd.), softazoline CL-R (30% aqueous solution, Kawaken Fine Chemical Co., Ltd.) and the like, and N-lauroyl-N-carboxymethyl-N- As hydroxyethylethylenediamine sodium, for example, softazolin LHL (27% aqueous solution, Kawaken Fine Chemical Co., Ltd.) is used, but in any case, the above is not restrictive.
(C)成分のベタイン型界面活性剤の配合量は、組成物全体の0.1〜2.0%、特に0.3〜1.5%が好適である。0.1%未満では口腔粘膜に対する刺激が強くなる場合があり、2.0%を超えると(C)成分由来の固有の苦味により、嫌味が強く生じる場合がある。 The blending amount of the component (C) betaine type surfactant is 0.1 to 2.0%, particularly 0.3 to 1.5% of the whole composition. If it is less than 0.1%, irritation to the oral mucosa may become strong, and if it exceeds 2.0%, an unpleasant taste may occur due to the inherent bitterness derived from the component (C).
(D)成分は、ピロリン酸塩及び/又はトリポリリン酸塩であり、イソプロピルメチルフェノール由来の浸透殺菌力の向上に有効である。ピロリン酸塩及びトリポリリン酸塩は、リン酸の脱水縮合によって生じた縮合リン酸塩であり、ピロリン酸塩は2量体であり、トリポリリン酸塩は3量体であり、直鎖状のポリリン酸塩である。これらの塩としては、ナトリウム、カリウム等のアルカリ金属塩、マグネシウム塩等のアルカリ土類金属塩などが挙げられるが、水溶解性などの点からナトリウム塩が好ましい。更に、溶解時のpHを中性域とするには、ピロリン酸塩では4ナトリウム塩、トリポリリン酸塩では5ナトリウム塩が好適である。これらのピロリン酸ナトリウム、トリポリリン酸ナトリウムとしては、例えば太平化学産業(株)などが用いられる。 The component (D) is pyrophosphate and / or tripolyphosphate, and is effective for improving the osmotic sterilization power derived from isopropylmethylphenol. Pyrophosphate and tripolyphosphate are condensed phosphates formed by dehydration condensation of phosphoric acid, pyrophosphate is a dimer, tripolyphosphate is a trimer, and linear polyphosphoric acid. Salt. Examples of these salts include alkali metal salts such as sodium and potassium, and alkaline earth metal salts such as magnesium salt. Sodium salts are preferred from the viewpoint of water solubility. Furthermore, in order to make pH at the time of dissolution into a neutral range, tetrasodium salt is preferable for pyrophosphate and pentasodium salt is preferable for tripolyphosphate. As these sodium pyrophosphate and sodium tripolyphosphate, for example, Taihei Chemical Industry Co., Ltd. is used.
(D)成分の縮合リン酸塩の配合量は、組成物全体の0.1〜2.0%、特に0.5〜1.5%が好ましい。配合量が0.1%未満では高い殺菌効果が得られず、2.0%を超えると口腔粘膜刺激が強くなる。 (D) The compounding quantity of the condensed phosphate of a component is 0.1 to 2.0% of the whole composition, and 0.5 to 1.5% is especially preferable. The amount can not be obtained a high sterilization effect is less than 0.1%, greater than 2.0% when the oral mucosal irritation may turn strongly.
(E)成分のラウリル硫酸塩は、歯磨組成物の発泡剤成分として広く用いられるものであり、その塩としてはナトリウム塩、カリウム塩等のアルカリ金属塩が挙げられる。ラウリル硫酸塩としては、特にラウリル硫酸ナトリウムが好ましく用いられる。 (E) The lauryl sulfate of a component is widely used as a foaming agent component of a dentifrice composition, As the salt, alkali metal salts, such as sodium salt and potassium salt, are mentioned. As lauryl sulfate, sodium lauryl sulfate is particularly preferably used.
ラウリル硫酸塩の配合量は、組成物全体の0.2〜2.5%、特に0.5〜1.5%が好ましい。0.2%未満では歯磨時に十分な泡立ちが得られなかったり、殺菌効果に劣る場合があり、2.5%を超えると粘膜刺激が強くなる場合がある。 The blending amount of lauryl sulfate is preferably 0.2 to 2.5%, particularly 0.5 to 1.5% of the entire composition. If it is less than 0.2%, sufficient foaming may not be obtained at the time of dentifrice, and the bactericidal effect may be inferior, and if it exceeds 2.5%, mucous membrane irritation may become strong.
(D)成分の縮合リン酸塩と(A)成分のイソプロピルメチルフェノールとの配合比率は、質量比で(D)成分/(A)成分が2〜100、特に10〜50が好ましい。配合比率が2未満の場合、あるいは100を超える場合は、いずれもバイオフィルムに対して高い殺菌効果が得られない場合がある。 The blending ratio of the (D) component condensed phosphate and the (A) component isopropylmethylphenol is preferably 2 to 100 (particularly 10 to 50) of (D) component / (A) component in mass ratio. When the blending ratio is less than 2 or more than 100, there are cases where a high bactericidal effect cannot be obtained for the biofilm.
また、(C)成分のベタイン型界面活性剤と(E)成分のラウリル硫酸塩との配合比率は、バイオフィルムに対してより高い殺菌効果を得る点で、質量比で(C)成分/(E)成分が0.1〜5、特に0.4〜2が好ましい。(C)成分/(E)成分の配合比率が0.1未満及では口腔粘膜刺激の低減が十分でない場合があり、5を超えると、バイオフィルムに対して高い殺菌効果が得られない場合がある。 In addition, the blending ratio of the (C) component betaine surfactant and the (E) component lauryl sulfate is such that (C) component / ( E) The component is preferably 0.1 to 5, particularly preferably 0.4 to 2. If the blending ratio of component (C) / component (E) is less than 0.1, reduction of oral mucosal irritation may not be sufficient, and if it exceeds 5, a high bactericidal effect may not be obtained for biofilms. is there.
更に、本発明では、(F)成分としてアニスアルデヒドを配合することが好ましく、(B)成分の香料成分に加えてアニスアルデヒドを添加することで、イソプロピルメチルフェノール由来の嫌味に対するマスキング効果をより高めることができ、より良好な香味を得ることができる。 Furthermore, in this invention, it is preferable to mix | blend anisaldehyde as (F) component, and by adding anisaldehyde in addition to the fragrance | flavor component of (B) component, the masking effect with respect to an odor derived from isopropylmethylphenol is improved more. And a better flavor can be obtained.
アニスアルデヒドとしては、大洋香料(株)の製品などの市販品を用いることができる。その配合量は、組成物全量に対して、0.0001〜0.1%、特に0.001〜0.02%が望ましい。配合量が0.0001%未満では、嫌味のマスキング効果を十分に高めることができない場合があり、0.1%を超えると、(B)成分と同様にアニスアルデヒド自体の香味が強すぎて嫌味を生じる場合がある。 As anisaldehyde, commercially available products such as products of Taiyo Perfume Co., Ltd. can be used. The blending amount is preferably 0.0001 to 0.1%, particularly 0.001 to 0.02%, based on the total amount of the composition. If the blending amount is less than 0.0001%, the masking effect of the tastelessness may not be sufficiently enhanced. If the amount exceeds 0.1%, the flavor of the anisaldehyde itself is too strong as in the case of the component (B). May occur.
(F)アニスアルデヒドを配合する場合、イソプロピルメチルフェノール由来の嫌味のマスキング効果をより高める点から、(B)成分と(F)成分の合計配合量が0.0002〜0.15%、特に0.002〜0.03%であることが望ましい。合計配合量が0.0002%未満では、嫌味のマスキング効果を十分高めることができない場合があり、0.15%を超えると、(B)及び(F)成分自体の香味が強すぎて嫌味を生じる場合がある。
なお、(B)成分と(F)成分との組み合わせとしては、特に3−オクタノールとアニスアルデヒドとの組み合わせが好ましく、これによりイソプロピルメチルフェノール由来の嫌味に対して、とりわけ優れたマスキング効果が発揮される。
When (F) anisaldehyde is blended, the total blending amount of the (B) component and the (F) component is 0.0002 to 0.15%, particularly 0, in order to further enhance the masking effect of the taste that is derived from isopropylmethylphenol. It is desirable to be 0.002 to 0.03%. If the total blending amount is less than 0.0002%, the masking effect of disgusting may not be sufficiently enhanced, and if it exceeds 0.15%, the flavors of the components (B) and (F) themselves are too strong to cause discomfort. May occur.
As the combination of the component (B) and the component (F), a combination of 3-octanol and anisaldehyde is particularly preferable, and an especially excellent masking effect is exerted with respect to an odor derived from isopropylmethylphenol. The
本発明の歯磨組成物は、上記した構成成分に加えて、本発明の効果を妨げない範囲で、通常歯磨組成物に配合されているその他の任意成分を必要に応じて配合することができる。例えば、研磨剤、界面活性剤、粘稠剤、粘結剤、甘味料、香料、着色料、防腐剤、pH調整剤、薬効成分等の適宜の成分を本発明の効果を損なわない範囲で配合し得る。 In the dentifrice composition of the present invention, in addition to the above-described constituent components, other optional components that are usually blended in the dentifrice composition can be blended as necessary within a range not impeding the effects of the present invention. For example, appropriate components such as abrasives, surfactants, thickeners, binders, sweeteners, fragrances, colorants, preservatives, pH adjusters, medicinal ingredients, and the like are blended within a range not impairing the effects of the present invention. Can do.
研磨剤としては、研磨性シリカ、第2リン酸カルシウム2水和物、第2リン酸カルシウム無水和物、ピロリン酸カルシウム、水酸化アルミニウム、アルミナ、二酸化チタン、ポリメチルメタアクリレート、不溶性メタリン酸カルシウム、軽質炭酸カルシウム、重質炭酸カルシウム、炭酸マグネシウム、第3リン酸マグネシウム、ゼオライト、ケイ酸ジルコニウム、ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト、第3リン酸カルシウム、第4リン酸カルシウム、第8リン酸カルシウムなどが挙げられる。研磨剤の配合量は、通常、組成物全体の10〜60%、特に15〜40%が好適である。 As abrasives, abrasive silica, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrate, calcium pyrophosphate, aluminum hydroxide, alumina, titanium dioxide, polymethyl methacrylate, insoluble calcium metaphosphate, light calcium carbonate, heavy Examples include calcium carbonate, magnesium carbonate, tribasic magnesium phosphate, zeolite, zirconium silicate, hydroxyapatite, fluoroapatite, calcium deficient apatite, tricalcium phosphate, tetracalcium phosphate, and eighth calcium phosphate. The blending amount of the abrasive is usually preferably 10 to 60%, particularly preferably 15 to 40% of the whole composition.
界面活性剤としては、(C)成分のベタイン型界面活性剤、(E)成分のラウリル硫酸塩に加え、その他のアニオン性界面活性剤、ノニオン性界面活性剤、両性界面活性剤等を添加してもよい。例えば、アニオン性界面活性剤としてはラウリル硫酸塩以外のアルキル硫酸塩、ポリオキシエチレンアルキル硫酸塩、N−ラウロイルタウリン塩、ラウロイルサルコシン塩、α−オレフィンスルホン酸塩等が挙げられる。ノニオン性界面活性剤として、例えばポリオキシエチレンアルキルエーテル、アルキルグリコシド、ショ糖脂肪酸エステル、アルキロールアマイド、ポリオキシエチレンソルビタンモノステアレート、ポリオキシエチレンポリオキシプロピレングリコール、脂肪酸ポリグリセリル、ポリオキシエチレン硬化ヒマシ油等が挙げられる。両性界面活性剤として、例えばN−アシルグルタメートなどが挙げられる。なお、これら他の界面活性剤の配合量は組成物全体の0〜3%程度、特に0〜2%であることが好ましい。 As the surfactant, in addition to the (C) component betaine type surfactant and the (E) component lauryl sulfate, other anionic surfactants, nonionic surfactants, amphoteric surfactants and the like are added. May be. For example, examples of the anionic surfactant include alkyl sulfates other than lauryl sulfate, polyoxyethylene alkyl sulfate, N-lauroyl taurine salt, lauroyl sarcosine salt, and α-olefin sulfonate. Nonionic surfactants include, for example, polyoxyethylene alkyl ether, alkyl glycoside, sucrose fatty acid ester, alkylol amide, polyoxyethylene sorbitan monostearate, polyoxyethylene polyoxypropylene glycol, fatty acid polyglyceryl, polyoxyethylene hardened castor Oil etc. are mentioned. Examples of amphoteric surfactants include N-acyl glutamate. In addition, it is preferable that the compounding quantity of these other surfactant is about 0 to 3% of the whole composition, and especially 0 to 2%.
粘稠剤としては、ソルビット、グリセリン、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ポリプロピレングリコール、キシリトール、マルチトール、エリスリトールなどの糖アルコール、多価アルコール等を配合してもよい。粘稠剤の配合量は通常10〜50%、特に20〜40%である。 As a thickener, sorbitol, glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol, polypropylene glycol, xylitol, maltitol, erythritol and other sugar alcohols, polyhydric alcohols, and the like may be blended. . The blending amount of the thickener is usually 10 to 50%, particularly 20 to 40%.
粘結剤としては、ポリアクリル酸ナトリウム、カラギーナン、カルボキシメチルセルロースナトリウム、アルギン酸ナトリウム、キサンタンガム、ヒドロキシエチルセルロースなどを配合できる。粘結剤の配合量は通常0.5〜2%である。 As the binder, sodium polyacrylate, carrageenan, sodium carboxymethyl cellulose, sodium alginate, xanthan gum, hydroxyethyl cellulose and the like can be blended. The amount of binder is usually 0.5-2%.
甘味料としては、サッカリンナトリウム、ステビオサイド、ネオヘスペリジルジヒドロカルコン、ペリラルチン、p−メトキシシンナミックアルデヒド、アスパルテーム等が配合できる。 As the sweetener, saccharin sodium, stevioside, neohesperidyl dihydrochalcone, perilartin, p-methoxycinnamic aldehyde, aspartame and the like can be blended.
(B)成分、更には(F)成分に加えて、その他の香料として、例えば、ユーカリ油、ウィンターグリーン油、カシア油、クローブ油、タイム油、セージ油、バジル油、カルダモン油、コリアンダー油、ペパーミント油、スペアミント油、ハッカ油、オレンジ油、レモン油、マンダリン油、ライム油、グレープフルーツ油、柚子油、スウィーティー油、ラベンダー油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、マジョラム油、セロリ油、ベイ油、オリガナム油、パインニードル油、ネロリ油、レモングラス油、ローズ油、ジャスミン油、パチュリ油、イリスコンクリート、ローズアブソリュート、オレンジフラワーアブソリュート、バニラアブソリュート、マンゴーアブソリュート、パチュリアブソリュート、ジンジャーオレオレジン、ペッパーオレオレジン、カプシカムオレオレジン、トウガラシ抽出物等の天然香料、及び、これら天然香料の加工処理(前溜部カット、後溜部カット、分留、液抽出、エッセンス化、粉末香料化等)した香料、及び、リモネン、ピネン、ブタノール、イソアミルアルコール、n−ヘキセノール、cis−3−ヘキセノール、cis−6−ノネノール、リナロール、α−テルピネオール、メントール、ベンジルアルコール、フェニルエチルアルコール、アネトール、チモール、メチルチャビコール、オイゲノール、カルボン、メントン、プレゴン、1,8−シネオール、ヨノン、キャロン、n−ヘキサナール、trans−2−ヘキセナール、シトラール、シンナムアルデヒド、ベンズアルデヒド、エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキシルアセテート、エチル2−メチルブチレート、アリルヘキサノエート、アリルシクロヘキサンプロピオネート、リナリルアセテート、メンチルアセテート、メンチルラクテート、カルビールアセテート、フェノキシエチルイソブチレート、メチルジャスモネート、サリチル酸メチル、サリチル酸エチル、メチルシンナメート、メチルアンスラニレート、フェニルエチルグリシデート、エチルラクテート、バニリン、マルトール、炭素数4〜12のガンマ及びデルタラクトン、アンブレットリド、ジメチルサルファイド、トリメチルピラジン、エチルβ−メチルチオプロピオネート、フラネオール、エチルシクロペンテノロン、シクロテン、2−メチルブチリックアシッド、プロピオニックアシッド、p−メトキシシンナミックアルデヒド、3−l−メントキシプロパン−1,2−ジオール、メントングリセリンアセタール、スピラントール、モノメンチルサクシネート、リナロールオキサイド、バニリルブチルエーテル、イソプレゴール等の単品香料、更に、ストロベリーフレーバー、アップルフレーバー、メロンフレーバー、バナナフレーバー、ピーチフレーバー、ラズベリーフレーバー、パイナップルフレーバー、グレープフレーバー、トロピカルフルーツフレーバー、マンゴーフレーバー、ウメフレーバー、オレンジフレーバー、レモンフレーバー、グレープフルーツフレーバー、ティーフレーバー、バターフレーバー、ミルクフレーバー等の調合香料、及び、エチルアルコール、プロピレングリコール、トリアセチン、グリセリン脂肪酸エステル等の香料溶剤等、歯磨組成物に用いられる公知の香料素材を組み合わせて使用することができる。これらの香料素材の配合量は特に限定されないが、組成物中に0.000001〜1%使用するのが好ましい。また、上記香料素材を使用した賦香用香料としては、組成物中に0.1〜2.0%使用するのが好ましい。 In addition to the component (B) and (F), other fragrances include, for example, eucalyptus oil, winter green oil, cassia oil, clove oil, thyme oil, sage oil, basil oil, cardamom oil, coriander oil, Peppermint oil, spearmint oil, peppermint oil, orange oil, lemon oil, mandarin oil, lime oil, grapefruit oil, coconut oil, sweetie oil, lavender oil, rosemary oil, laurel oil, camomil oil, caraway oil, marjoram oil, Celery oil, bay oil, origanum oil, pine needle oil, neroli oil, lemongrass oil, rose oil, jasmine oil, patchouli oil, Iris concrete, rose absolute, orange flower absolute, vanilla absolute, mango absolute, patchoulia absolute, ginger Natural fragrances such as leoresin, pepper oleoresin, capsicum oleoresin, pepper extract, and processing of these natural fragrances (front reservoir cut, rear reservoir cut, fractional distillation, liquid extraction, essence, powder flavor Perfume and limonene, pinene, butanol, isoamyl alcohol, n-hexenol, cis-3-hexenol, cis-6-nonenol, linalool, α-terpineol, menthol, benzyl alcohol, phenylethyl alcohol, anethole, Thymol, methylchavicol, eugenol, carvone, menthone, pregon, 1,8-cineole, yonon, caron, n-hexanal, trans-2-hexenal, citral, cinnamaldehyde, benzaldehyde, ethyl acetate, ethyl buty Rate, isoamyl acetate, hexyl acetate, ethyl 2-methylbutyrate, allyl hexanoate, allyl cyclohexane propionate, linalyl acetate, menthyl acetate, menthyl lactate, carbyl acetate, phenoxyethyl isobutyrate, methyl jasmonate, Methyl salicylate, ethyl salicylate, methyl cinnamate, methyl anthranilate, phenyl ethyl glycidate, ethyl lactate, vanillin, maltol, gamma and delta lactones having 4 to 12 carbon atoms, ambretlide, dimethyl sulfide, trimethylpyrazine, ethyl β -Methylthiopropionate, furaneol, ethylcyclopentenolone, cycloten, 2-methylbutyric acid, propionic acid, p Single fragrances such as methoxycinnamic aldehyde, 3-l-menthoxypropane-1,2-diol, menthone glycerin acetal, spiranthol, monomenthyl succinate, linalool oxide, vanillyl butyl ether, isopulegol, strawberry flavor, apple flavor , Melon flavor, banana flavor, peach flavor, raspberry flavor, pineapple flavor, grape flavor, tropical fruit flavor, mango flavor, ume flavor, orange flavor, lemon flavor, grapefruit flavor, tea flavor, butter flavor, milk flavor, etc. , And ethyl alcohol, propylene glycol, triacetin, glycerin fat Known perfume materials used in dentifrice compositions, such as perfume solvents such as acid esters, can be used in combination. Although the compounding quantity of these fragrance | flavor raw materials is not specifically limited, It is preferable to use 0.000001 to 1% in a composition. Moreover, as a fragrance | flavor for perfume using the said fragrance | flavor raw material, it is preferable to use 0.1 to 2.0% in a composition.
着色料としては、赤色2号、赤色3号、赤色225号、赤色226号、黄色4号、黄色5号、黄色205号、青色1号、青色2号、青色201号、青色204号、緑色3号、雲母チタン、酸化チタン等を挙げることができる。 As coloring agents, Red No. 2, Red No. 3, Red No. 225, Red No. 226, Yellow No. 4, Yellow No. 5, Yellow No. 205, Blue No. 1, Blue No. 2, Blue No. 201, Blue No. 204, Green No. 3, mica titanium, titanium oxide and the like.
防腐剤としては、パラオキシ安息香酸エステル、安息香酸ナトリウム等が挙げられる。 Examples of the preservative include paraoxybenzoic acid ester and sodium benzoate.
pH調整剤としては、例えばクエン酸、リンゴ酸、乳酸、酒石酸、酢酸、リン酸、ピロリン酸、グリセロリン酸やこれらの各種塩、水酸化ナトリウムなどを挙げることができる。本発明の歯磨組成物は、pH6〜10、特に7〜9に調整されることが好ましい。 Examples of the pH adjuster include citric acid, malic acid, lactic acid, tartaric acid, acetic acid, phosphoric acid, pyrophosphoric acid, glycerophosphoric acid, various salts thereof, sodium hydroxide, and the like. It is preferable that the dentifrice composition of this invention is adjusted to pH 6-10, especially 7-9.
薬効成分としては、イソプロピルメチルフェノールに加えて、フッ化ナトリウム、フッ化カリウム、フッ化第1錫、フッ化ストロンチウム、モノフルオロリン酸ナトリウム等のフッ化物、クロルヘキシジン、トリクロサン、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、クロルヘキシジン塩類、ソルビン酸塩、ヒノキチオール、アズレンスルホン酸塩等の抗菌性物質、プロテアーゼ、グルカナーゼ、リゾチーム等の分解酵素、トラネキサム酸、イプシロンアミノカプロン酸、アラントイン、グリチルリチン酸、グリチルレチン酸等の抗炎症物質、塩化ナトリウム、硝酸カリウム、乳酸アルミニウム、塩化亜鉛、クエン酸亜鉛、塩化ストロンチウムなどの無機塩類、ゼオライト、銅クロロフィリンナトリウム、クロロフィル、グリセロホスフェートなどのキレート性化合物、アスコルビン酸、酢酸トコフェロール、ピリドキシン等の各種ビタミン類、トウキ軟エキス、オウバクエキス、カミツレ、チョウジ、ローズマリー、オウゴン、ベニバナ等の天然抽出物などが挙げられる。これら有効成分の配合量は、本発明の効果を妨げない範囲で有効量とすることができる。 Medicinal ingredients include isopropylmethylphenol, fluorides such as sodium fluoride, potassium fluoride, stannous fluoride, strontium fluoride, sodium monofluorophosphate, chlorhexidine, triclosan, cetylpyridinium chloride, benzaza chloride Antibacterial substances such as luconium, benzethonium chloride, chlorhexidine salts, sorbate, hinokitiol, azulene sulfonate, proteases such as protease, glucanase, lysozyme, tranexamic acid, epsilon aminocaproic acid, allantoin, glycyrrhizic acid, glycyrrhetinic acid, etc. Anti-inflammatory substances, sodium chloride, potassium nitrate, aluminum lactate, zinc chloride, zinc citrate, strontium chloride and other inorganic salts, zeolite, copper chlorophyllin sodium, chloro And chelating compounds such as glyceryl phosphate, various vitamins such as ascorbic acid, tocopherol acetate, and pyridoxine, and natural extracts such as camphor, soft extract, duckweed extract, chamomile, clove, rosemary, ugone, safflower, etc. . The compounding quantity of these active ingredients can be made into an effective quantity in the range which does not prevent the effect of this invention.
本発明の歯磨組成物を収容する容器の材質は特に制限されず、通常、歯磨組成物に使用される容器を使用できる。具体的には、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロン等のプラスチック容器等が使用できる。 The material in particular of the container which accommodates the dentifrice composition of this invention is not restrict | limited, Usually, the container used for a dentifrice composition can be used. Specifically, plastic containers such as polyethylene, polypropylene, polyethylene terephthalate, and nylon can be used.
以下、実施例及び比較例を示して本発明を具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、以下の例において%は特に記載のない限りいずれも質量%である。 EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples,% is mass% unless otherwise specified.
〔実施例、比較例〕
表1〜3に示す組成の歯磨組成物を下記製造法により調製し、下記評価を行った。結果を表1〜3に示す。
(製造法)
(1)精製水中に(D)成分及び水溶性成分(粘結剤、プロピレングリコールを除く)を常温で混合溶解させたA相を調製した。
(2)プロピレングリコール中に(A)成分:イソプロピルメチルフェノールを溶解させた後、粘結剤を常温で分散させたB相を調製した。
(3)撹拌中のA相の中にB相を添加混合し、C相を調製した。
(4)C相中に、(B)成分、必要により(F)成分、及び表4,5に示した香料成分、研磨剤等の水溶性成分以外の成分、更に(C)成分、(E)成分の界面活性剤を、1.5Lニーダー(石山工作所製)を用い常温で混合し、減圧(4kPa)による脱泡を行い、歯磨組成物1.2kgを得た。
Examples and comparative examples
A dentifrice composition having the composition shown in Tables 1 to 3 was prepared by the following production method and evaluated as follows. The results are shown in Tables 1-3.
(Production method)
(1) A phase A was prepared by mixing and dissolving the component (D) and water-soluble components (excluding the binder and propylene glycol) in purified water at room temperature.
(2) Component (A) in propylene glycol: After dissolving isopropylmethylphenol, a phase B in which a binder was dispersed at room temperature was prepared.
(3) B phase was added and mixed in A phase under stirring, and C phase was prepared.
(4) In phase C, component (B), if necessary, component (F) and components other than water-soluble components such as fragrance components and abrasives shown in Tables 4 and 5, and (C) component, (E ) Component surfactant was mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Factory), defoamed under reduced pressure (4 kPa) to obtain 1.2 kg of a dentifrice composition.
これら歯磨組成物の調製に用いた各成分は、研磨性シリカ(Tixosil73、ローディア日華(株)、メジアン径14μm)、ラウリル硫酸ナトリウム(東邦化学工業(株))、ソルビット(70%水溶液品、東和化成工業(株))、グリセリン(85%水溶液品、ライオンケミカル(株))、イソプロピルメチルフェノール(大阪化成(株))、ヤシ油脂肪酸アミドプロピルベタイン液(30%水溶液品 TEGO BETAIN CK、Goldschmidt社)、ラウリン酸アミドプロピルベタイン(30%水溶液品、アンヒトール20AB、花王(株))、N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウム(40%水溶液品(固形分)、エナジコールC−40H、ライオン(株))、無水ピロリン酸ナトリウム(太平化学産業(株))、トリポリリン酸ナトリウム(太平化学産業(株))、3−オクタノール(塩野香料(株))、3−オクチルアセテート((株)井上香料製造所)、3−オクタノン((株)井上香料製造所)、フェンコン(香栄興業(株))、アニスアルデヒド(大洋香料(株))、1−オクタノール(高砂香料工業(株))、その他成分である、アルギン酸ナトリウム、プロピレングリコール、サッカリンナトリウム、フッ化ナトリウム、水については医薬部外品原料規格2006に適合したものを用いた。形態が水溶液の成分については、表中も含めいずれも純分換算の配合量を示した。任意に添加される香料成分として、表4,5に示す香料組成を用い香料組成物A〜Iを作製し、配合した。 Each component used for the preparation of these dentifrice compositions was abrasive silica (Tixosil 73, Rhodia Nikka Co., Ltd., median diameter 14 μm), sodium lauryl sulfate (Toho Chemical Co., Ltd.), Sorbit (70% aqueous solution product, Towa Kasei Kogyo Co., Ltd.), glycerin (85% aqueous solution, Lion Chemical Co., Ltd.), isopropylmethylphenol (Osaka Kasei Co., Ltd.), coconut oil fatty acid amidopropyl betaine solution (30% aqueous solution TEGO BETAIN CK, Goldschmidt Co., Ltd.), amidopropyl betaine laurate (30% aqueous solution, Amhitoal 20AB, Kao Corporation), N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine sodium (40% aqueous solution (solid content) , Enigol C-40H, Lion ( )), Anhydrous sodium pyrophosphate (Taihei Chemical Industrial Co., Ltd.), sodium tripolyphosphate (Taihei Chemical Industrial Co., Ltd.), 3-octanol (Shiono Fragrance Co., Ltd.), 3-octyl acetate (Inoue Fragrance Co., Ltd.) ), 3-Octanone (Inoue Fragrance Co., Ltd.), Fencon (Koei Kogyo Co., Ltd.), Anisaldehyde (Taiyo Fragrance Co., Ltd.), 1-octanol (Takasago Fragrance Co., Ltd.), other components As for sodium alginate, propylene glycol, sodium saccharin, sodium fluoride, and water, those conforming to the Quasi-drug raw material standard 2006 were used. About the component whose form is aqueous solution, all showed the compounding quantity of pure part conversion also including the table | surface. As optional fragrance components, fragrance compositions A to I were prepared and blended using the fragrance compositions shown in Tables 4 and 5.
得られた歯磨組成物を、最内層が直鎖状低密度ポリエチレンからなる直径26mmのラミネートチューブ(LDPE55/PET12/LDPE20/白LDPE60/EMAA20/AL10/EMAA30/LDPE20/LLDPE30、厚み257μm(大日本印刷(株)製))に50g充填した。
使用したラミネートチューブの層構成における略号と名称は以下の通りであり、略号に続く数字は各層の厚み(μm)を示したものである。
LDPE:低密度ポリエチレン
白LDPE:白色低密度ポリエチレン
LLDPE:直鎖状低密度ポリエチレン
AL:アルミニウム
PET:ポリエチレンテレフタレート
EMAA:エチレン・メタクリル酸の共重合体樹脂
The obtained dentifrice composition was a laminate tube (LDPE55 / PET12 / LDPE20 / white LDPE60 / EMAA20 / AL10 / EMAA30 / LDPE20 / LLDPE30, thickness 257 μm (Dai Nippon Printing Co., Ltd.) whose innermost layer was composed of linear low density polyethylene. 50 g) was filled.
The abbreviations and names in the layer structure of the laminated tube used are as follows, and the numbers following the abbreviations indicate the thickness (μm) of each layer.
LDPE: Low density polyethylene white LDPE: White low density polyethylene LLDPE: Linear low density polyethylene AL: Aluminum PET: Polyethylene terephthalate EMAA: Ethylene / methacrylic acid copolymer resin
歯磨組成物の(1)モデルバイオフィルム殺菌効果、(2)嫌味のなさ、(3)歯磨時の泡立ちの評価、(4)刺激のなさの評価については、以下の方法により評価した。 (1) Model biofilm bactericidal effect of dentifrice composition, (2) No taste, (3) Evaluation of foaming at the time of dentifrice, (4) Evaluation of no irritation was evaluated by the following methods.
(1)モデルバイオフィルム殺菌効果の評価法
直径7mmのハイドロキシアパタイト(HA)板を0.45μmのフィルターで濾過した人無刺激唾液で4時間処理し、ヘミン及びメナジオンを添加したトリプチケースソイブロス中、ストレプトコッカス ミュータンス(Streptococcus mutans)、アクチノマイセス ナエスランディ(Actinomyces naeslundii)、ベイヨネラ パルビュラ(Veillonella parvula)、フゾバクテリウム ヌクレアタム(Fusobacterium nucleatum)及びポルフィロモナス ジンジバリス(Porphyromonas gingivalis)の5菌種混合系で2週間連続培養することにより、HA板上にモデルバイオフィルムを形成させた。2週間培養後より1日1回、下記表1〜3に示した歯磨製剤に人口唾液(50mmol/L KCl+1mmol/L KH2PO4+1mmol/L CaCl2+0.1mmol/L MgCl2(pH7.0))を2倍質量添加し、分散させた後の遠心上清を試験薬剤液として、これにモデルバイオフィルムを3分間浸漬処理し、更に3日間培養した。培養終了時にモデルバイオフィルムを取り出し、分散後、寒天平板上で培養することによりモデルバイオフィルム中の各菌種の生菌数を求めた。生菌数は、培養条件により多少振れるが、試験薬剤液の代わりに人口唾液を作用させた場合では、約8.5log cfu(colony forming units/HA板)であった。本発明にかかわるモデルバイオフィルム殺菌効果の向上効果を以下の評価基準で判断し、5.0log cfu/HA板未満の場合において、バイオフィルム殺菌力が高いと判断した。
◎:4.5log cfu/HA板未満
○:4.5log cfu/HA板以上〜5.0log cfu/HA板未満
△:5.0log cfu/HA板以上〜6.0log cfu/HA板未満
×:6.0log cfu/HA板以上
(1) Evaluation method of model biofilm bactericidal effect Triptychase soy broth treated with human unstimulated saliva filtered through a 0.45 μm filter with a 7 mm diameter hydroxyapatite (HA) plate and added with hemin and menadione Among them, Streptococcus mutans, Actinomyces naeslundii, Veillonella parvula, Fusobacterium nuclatum, Fusobacterium nucleatum A model biofilm is formed on the HA plate by continuous culture for a week. Made. Once a day after culturing for two weeks, artificial saliva (50 mmol / L KCl + 1 mmol / L KH 2 PO 4 +1 mmol / L CaCl 2 +0.1 mmol / L MgCl 2 (pH 7.0) was added to the dentifrice formulations shown in Tables 1 to 3 below. )) Was added twice as much and dispersed, and the centrifuged supernatant was used as a test drug solution. The model biofilm was immersed in the solution for 3 minutes and further cultured for 3 days. At the end of the culture, the model biofilm was taken out, dispersed, and cultured on an agar plate to determine the number of viable bacteria of each bacterial species in the model biofilm. Although the number of viable bacteria fluctuated somewhat depending on the culture conditions, it was about 8.5 log cfu (colony forming units / HA plate) when artificial saliva was used instead of the test drug solution. The improvement effect of the model biofilm sterilization effect according to the present invention was judged according to the following evaluation criteria, and in the case of less than 5.0 log cfu / HA plate, the biofilm sterilization power was judged to be high.
A: Less than 4.5 log cfu / HA plate B: More than 4.5 log cfu / HA plate to less than 5.0 log cfu / HA plate Δ: More than 5.0 log cfu / HA plate to less than 6.0 log cfu / HA plate ×: More than 6.0 log cfu / HA board
(2)嫌味のなさ
専門家パネラー10人を用いた官能試験を実施した。口径8mmのラミネートチューブに充填した試験歯磨組成物約1gを市販品歯ブラシに載せて、通常歯を磨く方法で3分間ブラッシングを行い、使用中に感じた嫌味のなさを、以下の評点に従って評価した。10名の評価結果の平均値を求め、以下の基準で◎及び○の評価が確保されるものを、嫌味のない歯磨組成物であると判断した。
(評点)
4点:嫌味が全くない
3点:嫌味がほとんどない
2点:嫌味がややある
1点:嫌味がある
(専門パネラー10人の評価結果を平均した値の判定基準)
◎ :3.7点以上〜4.0点以下
◎〜○:3.3点以上〜3.7点未満
○ :3.0点以上〜3.3点未満
△ :2.0点以上〜3.0点未満
× :2.0点未満
(2) Lack of taste A sensory test was conducted using 10 expert panelists. About 1 g of the test dentifrice composition filled in an 8 mm diameter laminated tube was placed on a commercially available toothbrush and brushed for 3 minutes by the usual brushing method, and the unpleasant taste felt during use was evaluated according to the following ratings: . An average value of the evaluation results of 10 people was obtained, and those for which evaluations of ◎ and ○ were ensured on the basis of the following criteria were judged to be toothpaste compositions without taste.
(Score)
4 points: no disgusting 3 points: little disgusting 2 points: slightly disgusting 1 point: disgusting (judgment criteria for the average of the evaluation results of 10 professional panelists)
◎: 3.7 points to 4.0 points ◎ to ○: 3.3 points to less than 3.7 points ○: 3.0 points to less than 3.3 points Δ: 2.0 points to 3 points Less than 0 point x: Less than 2.0 point
(3)歯磨時の泡立ちの評価
専門家パネラー10人を用いた官能試験により評価した。歯ブラシ上に約1.5cmの試験歯磨組成物を乗せ、通常歯を磨く方法で使用し、使用中の口腔内での歯磨組成物の歯磨時の泡立ちについて以下の基準で評価した。
4点:泡立ち量が十分にあり、使用感に優れる。
3点:泡立ち量が適度にあり、使用感は満足できる。
2点:泡立ち量が少なく、使用感がやや劣る。
1点:泡立ちが殆どなく、使用感が悪い。
10名の評価結果を平均し、以下の基準で示し、◎及び○を歯磨時の泡立ちが確保され、満足できる使用感が得られる歯磨組成物であると判断した。
◎:口腔内での泡立ちが3.5点以上〜4.0点以下
○:口腔内での泡立ちが3.0点以上〜3.5点未満
△:口腔内での泡立ちが2.0点以上〜3.0点未満
×:口腔内での泡立ちが2.0点未満
(3) Evaluation of foaming at the time of dentifrice It evaluated by the sensory test using ten expert panelists. About 1.5 cm of the test dentifrice composition was placed on a toothbrush and used in a normal brushing method. The foaming of the dentifrice composition in the oral cavity during use was evaluated according to the following criteria.
4 points: The amount of foaming is sufficient and the feeling of use is excellent.
3 points: The amount of foaming is moderate and the feeling of use is satisfactory.
2 points: The amount of foaming is small and the feeling of use is slightly inferior.
1 point: There is almost no foaming and the feeling of use is bad.
The evaluation results of 10 people were averaged and indicated by the following criteria, and ◎ and ○ were judged to be a dentifrice composition that ensured foaming during dentifrice and gave a satisfactory feeling of use.
◎: Bubbling in the oral cavity is 3.5 points to 4.0 points or less ○: Bubbling in the oral cavity is 3.0 points to less than 3.5 points △: Bubbling in the oral cavity is 2.0 points Or more to less than 3.0 points x: foaming in the oral cavity is less than 2.0 points
(4)刺激のなさの評価
専門家パネラー10人を用いた官能試験により評価した。歯磨剤約1gを市販品歯ブラシに載せて3分間ブラッシングを行い、使用中に感じた舌及び口腔粘膜刺激について以下の基準で評価した。
評価基準;
4点:刺激が全くない
3点:刺激がほとんどない
2点:刺激がややある
1点:刺激がある
10名の評価結果を平均し、以下の基準で◎及び○の評価が確保されるものを、刺激のない歯磨組成物であると判断した。
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満
(4) Evaluation of non-stimulation Evaluation was made by a sensory test using 10 expert panelists. About 1 g of the dentifrice was placed on a commercially available toothbrush and brushed for 3 minutes. The tongue and oral mucosal irritation felt during use was evaluated according to the following criteria.
Evaluation criteria;
4 points: no stimulation at all 3 points: little stimulation 2 points: some stimulation 1 point: there is stimulation Average evaluation results of 10 people, and ◎ and ○ evaluations are secured according to the following criteria Was determined to be an unstimulated dentifrice composition.
◎: 3.5 points or more and 4.0 points or less ○: 3.0 points or more and less than 3.5 points △: 2.0 points or more and less than 3.0 points ×: Less than 2.0 points
表1の結果から、本発明のイソプロピルメチルフェノールを含有する歯磨組成物は、イソプロピルメチルフェノール特有な嫌味が低減され、バイオフィルムに対して高い殺菌効果を発揮し、口腔粘膜に対する刺激が少なく、歯磨時の泡立ちも良好であることが確認された。 From the results shown in Table 1, the dentifrice composition containing isopropylmethylphenol of the present invention has a reduced taste taste specific to isopropylmethylphenol, exhibits a high bactericidal effect on biofilms, has little irritation to the oral mucosa, and dentifrice It was confirmed that the foaming at the time was also good.
表2の結果から、本発明の必須要件のいずれかを欠く場合は、イソプロピルメチルフェノール特有な嫌味の低減効果、浸透殺菌力、口腔粘膜に対する刺激性、歯磨時の泡立ちのいずれかに劣り、本発明の目的は達成できなかった。 From the results of Table 2, if any of the essential requirements of the present invention is lacking, it is inferior to any of the tasting effects peculiar to isopropylmethylphenol, penetrating bactericidal power, irritation to oral mucosa, and foaming during dentifrice. The object of the invention could not be achieved.
表3の結果から、(A)〜(E)成分に加えて、更に(F)アニスアルデヒドを配合すると、嫌味がより低減し、嫌味のない香味発現性がより高まることがわかった。 From the results in Table 3, it was found that when (F) anisaldehyde was further added in addition to the components (A) to (E), the taste was further reduced and the flavor development without taste was further enhanced.
ノン、フェンコン、アニスアルデヒドは含まれない。
Claims (6)
(B)3−オクタノール、3−オクチルアセテート、3−オクタノンから選ばれる1種又は2種以上の香料成分、
(C)脂肪酸の炭素数が12〜14の脂肪酸アミドプロピルベタイン及び/又は2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、
(D)ピロリン酸塩及び/又はトリポリリン酸塩、
(E)ラウリル硫酸塩
を含有してなり、(D)成分の配合量が0.1〜2.0質量%であることを特徴とする歯磨組成物。 (A) isopropylmethylphenol,
(B) 1 type, or 2 or more types of fragrance | flavor components chosen from 3-octanol, 3-octyl acetate, and 3-octanone,
(C) Fatty acid amide propyl betaine and / or 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine whose fatty acid has 12 to 14 carbon atoms,
(D) pyrophosphate and / or tripolyphosphate,
(E) A dentifrice composition comprising lauryl sulfate, wherein the blending amount of component (D) is 0.1 to 2.0% by mass.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009255150A JP5493730B2 (en) | 2009-11-06 | 2009-11-06 | Dentifrice composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009255150A JP5493730B2 (en) | 2009-11-06 | 2009-11-06 | Dentifrice composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011098915A JP2011098915A (en) | 2011-05-19 |
JP5493730B2 true JP5493730B2 (en) | 2014-05-14 |
Family
ID=44190414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009255150A Active JP5493730B2 (en) | 2009-11-06 | 2009-11-06 | Dentifrice composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5493730B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104023539A (en) * | 2011-12-06 | 2014-09-03 | 荷兰联合利华有限公司 | Antimicrobial composition |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6007660B2 (en) * | 2012-08-08 | 2016-10-12 | ライオン株式会社 | Oral composition and calculus formation inhibitor |
WO2015008824A1 (en) * | 2013-07-18 | 2015-01-22 | ライオン株式会社 | Elimination agent for oral cavity biofilm and oral cavity composition |
JP6451392B2 (en) * | 2015-02-19 | 2019-01-16 | ライオン株式会社 | Oral composition |
JP7172028B2 (en) * | 2017-11-30 | 2022-11-16 | ライオン株式会社 | oral composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4983394A (en) * | 1990-05-03 | 1991-01-08 | Warner-Lambert Company | Flavor enhancing and medicinal taste masking agent |
DE19920147A1 (en) * | 1999-05-03 | 2000-11-09 | Haarmann & Reimer Gmbh | Mint and / or fruit flavor compositions |
EP1698324A1 (en) * | 2004-11-09 | 2006-09-06 | The Procter & Gamble Company | Zinc-containing dentifrice compositions having an improved taste |
JP2006182705A (en) * | 2004-12-28 | 2006-07-13 | Lion Corp | Article to be put on tooth and method for supplying oral cavity care substance |
JP2007254396A (en) * | 2006-03-23 | 2007-10-04 | Takasago Internatl Corp | Aroma component volatilization method |
JP2008143824A (en) * | 2006-12-08 | 2008-06-26 | Lion Corp | Dentifrice composition |
JP2008143825A (en) * | 2006-12-08 | 2008-06-26 | Lion Corp | Tooth paste composition |
-
2009
- 2009-11-06 JP JP2009255150A patent/JP5493730B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104023539A (en) * | 2011-12-06 | 2014-09-03 | 荷兰联合利华有限公司 | Antimicrobial composition |
Also Published As
Publication number | Publication date |
---|---|
JP2011098915A (en) | 2011-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5597970B2 (en) | Dentifrice composition | |
JP5597969B2 (en) | Dentifrice composition | |
JP5625647B2 (en) | Dentifrice composition | |
WO2011055708A1 (en) | Isopropyl methyl phenol-containing liquid composition for oral cavity | |
JP2010037318A (en) | Dentifrice composition | |
JP5493731B2 (en) | Dentifrice composition | |
JP2008156308A (en) | Composition for oral cavity | |
JP5493730B2 (en) | Dentifrice composition | |
JP2020011951A (en) | Oral composition | |
JP5600872B2 (en) | Toothpaste composition | |
JP2011105647A (en) | Dentifrice composition | |
JP2011098921A (en) | Composition for oral cavity | |
CN111902125B (en) | Oral composition and bitterness improver of alpha-olefin sulfonate | |
JP4892949B2 (en) | Dentifrice composition | |
JP5825088B2 (en) | Liquid oral composition | |
JP2009137897A (en) | Dentifrice composition | |
JP4158036B2 (en) | Dentifrice composition and method for producing the same | |
JP5471318B2 (en) | Dentifrice composition | |
KR102651630B1 (en) | Dentistry composition | |
JP2012180342A (en) | Dentifrice composition and method for enhancing antiseptic power of dentifrice composition | |
JP2012077032A (en) | Oral composition | |
JP2010143842A (en) | Dentifrice composition | |
JP7172028B2 (en) | oral composition | |
JP6206153B2 (en) | Dentifrice composition and dental dentinal tubule sealant | |
JP7567791B2 (en) | Composition for oral cavity and agent for providing massage sensation to gums |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120718 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130912 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130924 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131113 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140217 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5493730 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |